Phase II trial of an endometrial regenerative stem cell product for congestive heart failure: the RECOVER-ERC trial.

Trial Profile

Phase II trial of an endometrial regenerative stem cell product for congestive heart failure: the RECOVER-ERC trial.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Mar 2014

At a glance

  • Drugs ERC 124 (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RECOVER-ERC
  • Most Recent Events

    • 22 Mar 2013 Interim safety results published in a Medistem media release.
    • 22 Mar 2013 Medistem published an update on RECOVER-ERC in Translational Medicine, according to a company media release.
    • 11 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top